Literature DB >> 9513779

Pharmacologic modification of radiation-induced late normal tissue injury.

J E Moulder1, M E Robbins, E P Cohen, J W Hopewell, W F Ward.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9513779     DOI: 10.1007/978-1-4615-5769-2_6

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


× No keyword cloud information.
  5 in total

1.  Model development and use of ACE inhibitors for preclinical mitigation of radiation-induced injury to multiple organs.

Authors:  Meetha Medhora; Feng Gao; Qingping Wu; Robert C Molthen; Elizabeth R Jacobs; John E Moulder; Brian L Fish
Journal:  Radiat Res       Date:  2014-10-31       Impact factor: 2.841

Review 2.  Modifying radiation damage.

Authors:  Kwanghee Kim; William H McBride
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

3.  Mitigation of late renal and pulmonary injury after hematopoietic stem cell transplantation.

Authors:  Eric P Cohen; Manpreet Bedi; Amy A Irving; Elizabeth Jacobs; Rade Tomic; John Klein; Colleen A Lawton; John E Moulder
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-11-19       Impact factor: 7.038

4.  Captopril and losartan for mitigation of renal injury caused by single-dose total-body irradiation.

Authors:  John E Moulder; Eric P Cohen; Brian L Fish
Journal:  Radiat Res       Date:  2010-10-26       Impact factor: 2.841

5.  Mitigation of experimental radiation nephropathy by renin-equivalent doses of angiotensin converting enzyme inhibitors.

Authors:  John E Moulder; Eric P Cohen; Brian L Fish
Journal:  Int J Radiat Biol       Date:  2014-09       Impact factor: 2.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.